Barclays PLC Axsome Therapeutics, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 97,988 shares of AXSM stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97,988
Previous 61,785
58.6%
Holding current value
$11.6 Million
Previous $5.55 Million
49.33%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$481 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$392 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$174 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$165 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.09B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...